Related Experiment Video
Updated: Jul 20, 2026

Drug-Induced Sleep Endoscopy (DISE) with Target Controlled Infusion (TCI) and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
Obstructive sleep apnoea among HIV patients.
V Lo Re1, S Schutte-Rodin, J R Kostman
1Division of Infectious Diseases, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA. vincent.lore@uphs.upenn.edu
Antiretroviral therapy can cause weight gain and lipodystrophy, increasing obstructive sleep apnoea (OSA) risk in HIV patients. Overweight, obesity, and lipodystrophy are key risk factors for OSA in this population.
Area of Science:
- Medical research
- Sleep medicine
- Infectious disease
Background:
- Antiretroviral therapy (ART) for HIV can cause body weight gain and lipodystrophy.
- These metabolic changes may contribute to sleep disturbances, including obstructive sleep apnoea (OSA).
Purpose of the Study:
- To investigate the prevalence and risk factors of OSA in HIV-infected patients.
- To identify clinical characteristics associated with OSA in this cohort.
Main Methods:
- Retrospective review of medical records of HIV-infected subjects diagnosed with OSA via polysomnography.
- Data collected between January 1, 2003, and December 31, 2004.
- Inclusion criteria: confirmed OSA (apnoea/hypopnoea index >= 5).
Main Results:
- Twelve HIV-infected subjects with confirmed OSA were identified.
- Common symptoms included daytime somnolence, fatigue, and snoring.
- High prevalence of overweight/obesity (92%), lipodystrophy (58%), and large neck circumference (>= 40 cm, 92%).
Conclusions:
- Overweight/obesity, lipodystrophy, and increased neck circumference are potential risk factors for OSA in HIV patients.
- Clinicians should screen HIV patients with these characteristics for OSA symptoms.
- Overnight polysomnography is crucial for diagnosing sleep disturbances like OSA in this population.
Related Concept Videos
Sleep Apnea
The condition is more prevalent among...
Other Pulmonary Disorders
Cryptococcal Meningitis
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Hyperpnea and Hyperventilation
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
